Updated outcomes and impact of age with lenalidomide and low-dose dexamethasone or melphalan, prednisone, and thalidomide in the randomized, phase III FIRST trial

Scientific publication - Journal Article uoadl:2951040 31 Read counter

Description
Contents

Unit:

Faculty of Medicine

Title:

Updated outcomes and impact of age with lenalidomide and low-dose dexamethasone or melphalan, prednisone, and thalidomide in the randomized, phase III FIRST trial

Languages of Item:

English

Abstract:

Empty abstract

Publication year:

2016

Authors:

Hulin, Cyrille
Belch, Andrew
Shustik, Chaim
Petrucci, Maria Teresa
Dührsen, Ulrich
Lu, Jin
Song, Kevin
Rodon, Philippe
Pégourié, Brigitte
Garderet, Laurent
others

Journal:

Chinese Journal of Clinical Oncology

Publisher:

American Society of Clinical Oncology

Volume:

Number:

Pages:

3609--3617

Main subject category:

Health Sciences

Persistent URL:

https://pergamos.lib.uoa.gr/uoa/dl/object/2951040

Updated outcomes and impact of age with lenalidomide and low-dose dexamethasone or melphalan, prednisone, and thalidomide in the randomized, phase III FIRST trial

The digital material of the item is not available.